Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LTA4H | P09960 | 1/20 | 0.56 |
| ▸ | ALOX5AP | P20292 | 1/20 | 0.48 |
| ▸ | FEN1 | P39748 | 1/20 | 0.48 |
| ▸ | PIK3CD | O00329 | 2/20 | 0.47 |
| ▸ | SCN10A | Q9Y5Y9 | 5/20 | 0.47 |
| ▸ | SCN5A | Q14524 | 4/20 | 0.47 |
| ▸ | KCNH2 | Q12809 | 3/20 | 0.47 |
| ▸ | SCN1A | P35498 | 1/20 | 0.47 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.47 |
| ▸ | SCN2A | Q99250 | 1/20 | 0.47 |
| ▸ | SCN8A | Q9UQD0 | 1/20 | 0.47 |
| ▸ | MKNK1 | Q9BUB5 | 1/20 | 0.46 |
| ▸ | MKNK2 | Q9HBH9 | 1/20 | 0.46 |
| ▸ | CA12 | O43570 | 1/20 | 0.46 |
| ▸ | CA9 | Q16790 | 1/20 | 0.46 |
| ▸ | CCNT1 | O60563 | 1/20 | 0.43 |
| ▸ | CCNA2 | P20248 | 1/20 | 0.43 |
| ▸ | CDK2 | P24941 | 1/20 | 0.43 |
| ▸ | CDK9 | P50750 | 1/20 | 0.43 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29603339 | 0.85 | ALOX5AP (0.49) | LTA4HALOX5APFEN1SCN10ASCN5A | |
| SCHEMBL2305476 | 0.85 | ALOX5AP (0.49) | LTA4HALOX5APFEN1SCN10ASCN5A | |
| SCHEMBL1333400 | 0.84 | ABL1 (0.53) | SCN10ASCN5AKCNH2SCN1ASCN9A | |
| Hydrochloric Acid SCHEMBL27039157 | 0.83 | ALOX5AP (0.48) | LTA4HALOX5APFEN1SCN10ASCN5A | |
| SCHEMBL4025534 | 0.82 | MAP4K4 (0.57) | LTA4HALOX5APFEN1PIK3CDSCN10A | |
| SCHEMBL23204199 | 0.82 | KCNH2 (0.51) | LTA4HALOX5APFEN1SCN10ASCN5A | |
| SCHEMBL17157363 | 0.80 | SCN5A (0.48) | SCN10ASCN5AKCNH2SCN1ASCN9A | |
| SCHEMBL1227164 | 0.80 | CHRM5 (0.52) | SCN10ASCN5AKCNH2SCN1ASCN9A | |
| SCHEMBL1742853 | 0.79 | CHRM5 (0.54) | PIK3CDSCN10ASCN5AKCNH2SCN1A | |
| SCHEMBL3265605 | 0.79 | MEN1 (0.47) | SCN10ASCN5AKCNH2SCN1ASCN9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9802914-B2 | Antifungal compound process | VIAMET PHARMACEUTICALS, INC. (US) | 2017-10-31 | — | — | US | disclosed |
| US-20170081309-A1 | ANTIFUNGAL COMPOUND PROCESS | Mycovia Pharmaceuticals, Inc. | 2017-03-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170081309-A1 | ANTIFUNGAL COMPOUND PROCESS | ERG28, DPM1, CYP51A1 | LTA4H 993/4885ALOX5AP 1967/4885FEN1 572/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.